phosphorus has been researched along with mifepristone in 5 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (mifepristone) | Trials (mifepristone) | Recent Studies (post-2010) (mifepristone) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 6,536 | 595 | 1,758 |
| Protein | Taxonomy | phosphorus (IC50) | mifepristone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Canis lupus familiaris (dog) | 0.0264 | |
| Bile salt export pump | Homo sapiens (human) | 2.02 | |
| Estrogen receptor | Homo sapiens (human) | 4.311 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.0249 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.0003 | |
| Progesterone receptor | Homo sapiens (human) | 0.1347 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.774 | |
| Glucocorticoid receptor | Mus musculus (house mouse) | 0.0022 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0022 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 2.0938 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 9.5 | |
| Coagulation factor VII | Homo sapiens (human) | 0.0003 | |
| Androgen receptor | Homo sapiens (human) | 0.2988 | |
| Cytochrome P450 2C8 | Homo sapiens (human) | 1.5 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 4.9 | |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Rattus norvegicus (Norway rat) | 0.0016 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.555 | |
| Tissue factor | Homo sapiens (human) | 0.0003 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0083 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0014 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0022 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0022 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0078 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0022 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 0.0015 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.457 | |
| Estrogen receptor beta | Homo sapiens (human) | 1.528 | |
| Glucocorticoid receptor | Sus scrofa (pig) | 0.0153 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dluhy, RG; Solomon, CG | 1 |
| Allan, G; Chen, X; Demarest, K; Fiordeliso, JJ; Gunnet, J; Jiang, W; Linton, O; Lundeen, S; Sui, Z; Tannenbaum, P; Xu, J; Zhu, P | 1 |
| Allan, G; Demarest, K; Fiordeliso, JJ; Gunnet, J; Jiang, W; Linton, O; Lundeen, S; Sui, Z; Tannenbaum, P; Xu, J; Zhu, P | 1 |
| Fatherazi, S; Foster, BL; Matsa-Dunn, D; Presland, RB; Rutherford, RB; Somerman, MJ | 1 |
| Felthaus, O; Gosau, M; Morsczeck, C | 1 |
5 other study(ies) available for phosphorus and mifepristone
| Article | Year |
|---|---|
Paraneoplastic endocrine syndromes.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndrome; Diazoxide; Diphosphonates; Estrogens; Fluid Therapy; Hemangiopericytoma; Humans; Hypercalcemia; Hyperthyroidism; Hypoglycemia; Inappropriate ADH Syndrome; Ketoconazole; Mifepristone; Mineralocorticoids; Mitotane; Octreotide; Osteomalacia; Pamidronate; Paraneoplastic Endocrine Syndromes; Phosphorus; Plicamycin; Propylthiouracil; Saline Solution, Hypertonic; Somatostatin; Thyroid Neoplasms | 1994 |
Novel phosphorus-containing 17beta-side chain mifepristone analogues as progesterone receptor antagonists.
Topics: Animals; Binding Sites; Cell Line; Female; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Phosphorus; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Structure-Activity Relationship | 2006 |
Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist.
Topics: Animals; Biological Availability; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Humans; Inhibitory Concentration 50; Mifepristone; Phosphorus; Rats; Receptors, Glucocorticoid; Steroids; Structure-Activity Relationship | 2007 |
Phosphate regulates osteopontin gene transcription.
Topics: Animals; Base Pairing; Cells, Cultured; Dental Cementum; Dexamethasone; Gene Expression Regulation, Bacterial; Glucocorticoids; Hormone Antagonists; Mice; Mifepristone; Mutation; Osteopontin; Phosphates; Phosphorus; Promoter Regions, Genetic; Receptors, Glucocorticoid; Response Elements; Signal Transduction; Transcription, Genetic; Transfection; Up-Regulation | 2009 |
ZBTB16 induces osteogenic differentiation marker genes in dental follicle cells independent from RUNX2.
Topics: Alkaline Phosphatase; Anthraquinones; Biomarkers; Calcification, Physiologic; Calcium; Cell Differentiation; Coloring Agents; Core Binding Factor Alpha 1 Subunit; Dental Sac; DNA-Binding Proteins; Durapatite; Gene Expression Regulation; Genetic Vectors; Glucocorticoids; Glycoproteins; Hormone Antagonists; Humans; Kruppel-Like Transcription Factors; Mifepristone; Osteoblasts; Osteocalcin; Osteogenesis; Phosphorus; Promyelocytic Leukemia Zinc Finger Protein; Real-Time Polymerase Chain Reaction; Receptors, Steroid; Receptors, Thyroid Hormone; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, X-Ray Emission; Stem Cells; Transfection | 2014 |